{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T07:04:23Z","timestamp":1766991863491,"version":"3.48.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda, M\u00e9xico","doi-asserted-by":"crossref","award":["SALUD\u20112014\u20111\u2011233886"],"award-info":[{"award-number":["SALUD\u20112014\u20111\u2011233886"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11380-8","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T05:32:09Z","timestamp":1766986329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic and epigenetic contribution of ABCG2 to gout susceptibility: a case-control study"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6399-9865","authenticated-orcid":false,"given":"Denise","family":"Clavijo-Cornejo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-2862","authenticated-orcid":false,"given":"Javier Fern\u00e1ndez","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4100-9346","authenticated-orcid":false,"given":"M\u00f3nica","family":"Santamaria-Olmedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1751-3454","authenticated-orcid":false,"given":"Yessica","family":"Zamudio-Cuevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0675-0227","authenticated-orcid":false,"given":"Karina","family":"Mart\u00ednez-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4103-4370","authenticated-orcid":false,"given":"Alba Paulina","family":"Flores-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2916-7424","authenticated-orcid":false,"given":"Ambar","family":"L\u00f3pez-Macay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"11380_CR1","doi-asserted-by":"crossref","unstructured":"Zhang Y et al (2022) Gout and diet: A comprehensive review of mechanisms and management. Nutrients, 14(17)","DOI":"10.3390\/nu14173525"},{"issue":"2","key":"11380_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ekir.2022.11.016","volume":"8","author":"RJ Johnson","year":"2023","unstructured":"Johnson RJ et al (2023) Uric acid and chronic kidney disease: still more to do. Kidney Int Rep 8(2):229\u2013239","journal-title":"Kidney Int Rep"},{"issue":"3S","key":"11380_CR3","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.semarthrit.2020.04.008","volume":"50","author":"JA Singh","year":"2020","unstructured":"Singh JA, Gaffo A (2020) Gout epidemiology and comorbidities. Semin Arthritis Rheum 50(3S):S11\u2013S16","journal-title":"Semin Arthritis Rheum"},{"key":"11380_CR4","doi-asserted-by":"crossref","unstructured":"Suo Y et al (2024) Molecular basis of the urate transporter URAT1 Inhibition by gout drugs. BioRxiv","DOI":"10.1101\/2024.09.11.612563"},{"issue":"6887","key":"11380_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature742","volume":"417","author":"A Enomoto","year":"2002","unstructured":"Enomoto A et al (2002) Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417(6887):447\u2013452","journal-title":"Nature"},{"issue":"1","key":"11380_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/annrheumdis-2019-216044","volume":"79","author":"T Higashino","year":"2020","unstructured":"Higashino T et al (2020) Dysfunctional missense variant of OAT10\/SLC22A13 decreases gout risk and serum uric acid levels. Ann Rheum Dis 79(1):164\u2013166","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"11380_CR7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1681\/ASN.2006040415","volume":"18","author":"Y Hagos","year":"2007","unstructured":"Hagos Y et al (2007) Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J Am Soc Nephrol 18(2):430\u2013439","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"11380_CR8","first-page":"393","volume":"6","author":"PI Patel","year":"1986","unstructured":"Patel PI et al (1986) Fine structure of the human hypoxanthine phosphoribosyltransferase gene. Mol Cell Biol 6(2):393\u2013403","journal-title":"Mol Cell Biol"},{"issue":"21\u201322","key":"11380_CR9","doi-asserted-by":"publisher","first-page":"6887","DOI":"10.1007\/s00018-021-03901-y","volume":"78","author":"S Kukal","year":"2021","unstructured":"Kukal S et al (2021) Multidrug efflux transporter ABCG2: expression and regulation. Cell Mol Life Sci 78(21\u201322):6887\u20136939","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"11380_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40001-022-00684-1","volume":"27","author":"PD Natsuko","year":"2022","unstructured":"Natsuko PD et al (2022) Differential gene expression of ABCG2, SLC22A12, IL-1beta, and ALPK1 in peripheral blood leukocytes of primary gout patients with hyperuricemia and their comorbidities: a case-control study. Eur J Med Res 27(1):62","journal-title":"Eur J Med Res"},{"issue":"11","key":"11380_CR11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41568-023-00612-3","volume":"23","author":"A Sajid","year":"2023","unstructured":"Sajid A, Rahman H, Ambudkar SV (2023) Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters. Nat Rev Cancer 23(11):762\u2013779","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"11380_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40101-025-00394-7","volume":"44","author":"FF Karwur","year":"2025","unstructured":"Karwur FF et al (2025) Anthropometric and metabolic differences and distribution of ABCG2 rs2231142 variant between lowland and Highland Papuans in West Papua, Indonesia. J Physiol Anthropol 44(1):14","journal-title":"J Physiol Anthropol"},{"issue":"1","key":"11380_CR13","doi-asserted-by":"publisher","first-page":"9679","DOI":"10.1038\/s41598-025-93312-x","volume":"15","author":"M Liang","year":"2025","unstructured":"Liang M et al (2025) Analysis of ABCG2 gene rs2231142 single nucleotide polymorphism and risk factors in hyperuricemia. Sci Rep 15(1):9679","journal-title":"Sci Rep"},{"key":"11380_CR14","doi-asserted-by":"crossref","unstructured":"Horvathova V et al (2019) Interaction of the p.Q141K variant of the ABCG2 gene with clinical data and cytokine levels in primary hyperuricemia and gout. J Clin Med, 8(11)","DOI":"10.3390\/jcm8111965"},{"issue":"13","key":"11380_CR15","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1073\/pnas.1214530110","volume":"110","author":"OM Woodward","year":"2013","unstructured":"Woodward OM et al (2013) Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules. Proc Natl Acad Sci U S A 110(13):5223\u20135228","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11380_CR16","doi-asserted-by":"publisher","first-page":"1422834","DOI":"10.3389\/fimmu.2024.1422834","volume":"15","author":"T Arumugam","year":"2024","unstructured":"Arumugam T et al (2024) Variation within the non-coding genome influences genetic and epigenetic regulation of the human leukocyte antigen genes. Front Immunol 15:1422834","journal-title":"Front Immunol"},{"issue":"7","key":"11380_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11926-016-0594-8","volume":"18","author":"AB Vargas-Santos","year":"2016","unstructured":"Vargas-Santos AB, Taylor WJ, Neogi T (2016) Gout classification criteria: update and implications. Curr Rheumatol Rep 18(7):46","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"11380_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","volume":"15","author":"T Bardin","year":"2017","unstructured":"Bardin T, Richette P (2017) Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med 15(1):123","journal-title":"BMC Med"},{"issue":"2","key":"11380_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/BOR.0000000000000779","volume":"33","author":"C Yokose","year":"2021","unstructured":"Yokose C, McCormick N, Choi HK (2021) The role of diet in hyperuricemia and gout. Curr Opin Rheumatol 33(2):135\u2013144","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"11380_CR20","doi-asserted-by":"publisher","first-page":"e0228684","DOI":"10.1371\/journal.pone.0228684","volume":"15","author":"M Son","year":"2020","unstructured":"Son M, Seo J, Yang S (2020) Association between dyslipidemia and serum uric acid levels in Korean adults: Korea National health and nutrition examination survey 2016\u20132017. PLoS ONE 15(2):e0228684","journal-title":"PLoS ONE"},{"key":"11380_CR21","doi-asserted-by":"crossref","unstructured":"Choi HG et al (2022) Association between gout and dyslipidemia: A nested Case-Control study using a National health screening cohort. J Pers Med, 12(4)","DOI":"10.3390\/jpm12040605"},{"issue":"1","key":"11380_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13075-023-03204-6","volume":"25","author":"A Kvasnicka","year":"2023","unstructured":"Kvasnicka A et al (2023) Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment. Arthritis Res Ther 25(1):234","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"11380_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s10038-023-01168-8","volume":"68","author":"M Ueda","year":"2023","unstructured":"Ueda M et al (2023) GLUT9 as a potential drug target for chronic kidney disease: drug target validation by a Mendelian randomization study. J Hum Genet 68(10):699\u2013704","journal-title":"J Hum Genet"},{"key":"11380_CR24","doi-asserted-by":"publisher","first-page":"156600","DOI":"10.1016\/j.phymed.2025.156600","volume":"140","author":"N Ding","year":"2025","unstructured":"Ding N et al (2025) Artemetin targets the ABCG2\/RAB7A axis to inhibit mitochondrial dysfunction in asthma. Phytomedicine 140:156600","journal-title":"Phytomedicine"},{"issue":"3","key":"11380_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/cbin.11100","volume":"43","author":"X Lu","year":"2019","unstructured":"Lu X et al (2019) IL-1beta functionally attenuates ABCG2 and PDZK1 expression in HK-2 cells partially through NF-kB activation. Cell Biol Int 43(3):279\u2013289","journal-title":"Cell Biol Int"},{"issue":"6","key":"11380_CR26","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/j.1471-4159.2010.06887.x","volume":"114","author":"S Shen","year":"2010","unstructured":"Shen S et al (2010) ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in alzheimer\u2019s disease. J Neurochem 114(6):1590\u20131604","journal-title":"J Neurochem"},{"issue":"9","key":"11380_CR27","first-page":"9812","volume":"8","author":"R Li","year":"2015","unstructured":"Li R et al (2015) A meta-analysis of the associations between the Q141K and Q126X ABCG2 gene variants and gout risk. Int J Clin Exp Pathol 8(9):9812\u20139823","journal-title":"Int J Clin Exp Pathol"},{"key":"11380_CR28","doi-asserted-by":"crossref","unstructured":"Duong NT et al (2019) Polymorphisms of ABCG2 and SLC22A12 genes associated with gout risk in Vietnamese population. Med (Kaunas), 55(1)","DOI":"10.3390\/medicina55010008"},{"issue":"7984","key":"11380_CR29","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41586-023-06595-3","volume":"622","author":"A Ziyatdinov","year":"2023","unstructured":"Ziyatdinov A et al (2023) Genotyping, sequencing and analysis of 140,000 adults from Mexico City. Nature 622(7984):784\u2013793","journal-title":"Nature"},{"issue":"1","key":"11380_CR30","doi-asserted-by":"publisher","first-page":"37209","DOI":"10.1038\/s41598-025-21071-w","volume":"15","author":"MA Trujillo-Jimenez","year":"2025","unstructured":"Trujillo-Jimenez MA et al (2025) Genetic ancestry influences body shape and obesity risk in Latin American populations. Sci Rep 15(1):37209","journal-title":"Sci Rep"},{"issue":"15","key":"11380_CR31","doi-asserted-by":"publisher","first-page":"e35477","DOI":"10.1016\/j.heliyon.2024.e35477","volume":"10","author":"S Romero-Hidalgo","year":"2024","unstructured":"Romero-Hidalgo S et al (2024) Selection scan in native Americans of Mexico identifies FADS2 rs174616: evidence of gene-diet interactions affecting lipid levels and Delta-6-desaturase activity. Heliyon 10(15):e35477","journal-title":"Heliyon"},{"key":"11380_CR32","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1038\/srep05227","volume":"4","author":"A Nakayama","year":"2014","unstructured":"Nakayama A et al (2014) Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors. Sci Rep 4:5227","journal-title":"Sci Rep"},{"key":"11380_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ijcard.2018.09.107","volume":"279","author":"LR Macias-Kauffer","year":"2019","unstructured":"Macias-Kauffer LR et al (2019) Genetic contributors to serum uric acid levels in Mexicans and their effect on premature coronary artery disease. Int J Cardiol 279:168\u2013173","journal-title":"Int J Cardiol"},{"key":"11380_CR34","doi-asserted-by":"publisher","first-page":"1074012","DOI":"10.3389\/fendo.2023.1074012","volume":"14","author":"CT Lin","year":"2023","unstructured":"Lin CT et al (2023) The ABCG2 rs2231142 polymorphism and the risk of nephrolithiasis: A case-control study from the Taiwan biobank. Front Endocrinol (Lausanne) 14:1074012","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"11380_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s10038-020-0821-z","volume":"66","author":"R Takei","year":"2021","unstructured":"Takei R et al (2021) Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects. J Hum Genet 66(2):161\u2013169","journal-title":"J Hum Genet"},{"key":"11380_CR36","first-page":"129","volume":"10","author":"MC Cleophas","year":"2017","unstructured":"Cleophas MC et al (2017) ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches. Pharmgenomics Pers Med 10:129\u2013142","journal-title":"Pharmgenomics Pers Med"},{"issue":"11","key":"11380_CR37","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1038\/s41588-024-01921-5","volume":"56","author":"TJ Major","year":"2024","unstructured":"Major TJ et al (2024) A genome-wide association analysis reveals new pathogenic pathways in gout. Nat Genet 56(11):2392\u20132406","journal-title":"Nat Genet"},{"issue":"1","key":"11380_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/imr.12833","volume":"294","author":"G Cabau","year":"2020","unstructured":"Cabau G et al (2020) Urate-induced immune programming: consequences for gouty arthritis and hyperuricemia. Immunol Rev 294(1):92\u2013105","journal-title":"Immunol Rev"},{"issue":"3","key":"11380_CR39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/08820139.2023.2168554","volume":"52","author":"JD de Lima","year":"2023","unstructured":"de Lima JD et al (2023) Genetic and epigenetic regulation of the innate immune response to gout. Immunol Invest 52(3):364\u2013397","journal-title":"Immunol Invest"},{"issue":"6","key":"11380_CR40","doi-asserted-by":"publisher","first-page":"e24451","DOI":"10.1002\/jcla.24451","volume":"36","author":"F Chen","year":"2022","unstructured":"Chen F et al (2022) Construction of LncRNA-miRNA-mRNA network based on CeRNA mechanism reveals the function of LncRNA in the pathogenesis of gout. J Clin Lab Anal 36(6):e24451","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"11380_CR41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s13577-020-00342-w","volume":"33","author":"A Nakashima","year":"2020","unstructured":"Nakashima A et al (2020) Dysfunctional ABCG2 gene polymorphisms are associated with serum uric acid levels and all-cause mortality in Hemodialysis patients. Hum Cell 33(3):559\u2013568","journal-title":"Hum Cell"},{"issue":"8","key":"11380_CR42","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1124\/dmd.121.000446","volume":"49","author":"X Wen","year":"2021","unstructured":"Wen X et al (2021) BCRP\/ABCG2 transporter regulates accumulation of cadmium in kidney cells: role of the Q141K variant in modulating nephrotoxicity. Drug Metab Dispos 49(8):629\u2013637","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"11380_CR43","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1016\/j.jprot.2012.04.040","volume":"75","author":"K Babu","year":"2012","unstructured":"Babu K et al (2012) Epigenetic regulation of ABCG2 gene is associated with susceptibility to xenobiotic exposure. J Proteom 75(12):3410\u20133418","journal-title":"J Proteom"},{"issue":"22","key":"11380_CR44","doi-asserted-by":"publisher","first-page":"8572","DOI":"10.1128\/MCB.00650-06","volume":"26","author":"KK To","year":"2006","unstructured":"To KK, Zhan Z, Bates SE (2006) Aberrant promoter methylation of the ABCG2 gene in renal carcinoma. Mol Cell Biol 26(22):8572\u20138585","journal-title":"Mol Cell Biol"},{"issue":"12","key":"11380_CR45","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1093\/rheumatology\/kead139","volume":"62","author":"T Zhao","year":"2023","unstructured":"Zhao T et al (2023) Intestinal uric acid excretion contributes to serum uric acid decrease during acute gout attack. Rheumatology (Oxford) 62(12):3984\u20133992","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"11380_CR46","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1038\/s41440-023-01391-y","volume":"46","author":"T Notsu","year":"2023","unstructured":"Notsu T et al (2023) Inhibition of the uric acid efflux transporter ABCG2 enhances stimulating effect of soluble uric acid on IL-1beta production in murine macrophage-like J774.1 cells. Hypertens Res 46(10):2368\u20132377","journal-title":"Hypertens Res"},{"issue":"4","key":"11380_CR47","first-page":"e57433","volume":"16","author":"PA Makhe","year":"2024","unstructured":"Makhe PA, Vagga AA (2024) Comparison of adenosine Deaminase, C-reactive Protein, uric Acid, and rheumatoid arthritis levels in patients with rheumatoid arthritis and those without arthritis: A review. Cureus 16(4):e57433","journal-title":"Cureus"},{"issue":"1","key":"11380_CR48","doi-asserted-by":"publisher","first-page":"11000","DOI":"10.1038\/s41598-022-15176-9","volume":"12","author":"KW Lee","year":"2022","unstructured":"Lee KW, Shin D (2022) Concurrent presence of high serum uric acid and inflammation is associated with increased incidence of type 2 diabetes mellitus in Korean adult population. Sci Rep 12(1):11000","journal-title":"Sci Rep"},{"issue":"5\u20136","key":"11380_CR49","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/15257770.2022.2051047","volume":"41","author":"PF Turker","year":"2022","unstructured":"Turker PF et al (2022) The correlation of uric acid levels with biochemical parameters and dietary factors in individuals with asymptomatic hyperuricemia and gouty arthritis. Nucleosides Nucleotides Nucleic Acids 41(5\u20136):444\u2013462","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"1","key":"11380_CR50","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1038\/s41598-022-08311-z","volume":"12","author":"AK Wessig","year":"2022","unstructured":"Wessig AK et al (2022) Natural antibodies and CRP drive anaphylatoxin production by urate crystals. Sci Rep 12(1):4483","journal-title":"Sci Rep"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11380-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11380-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11380-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T07:01:31Z","timestamp":1766991691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11380-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11380"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11380-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki Declaration and its later amendments. The study was approved by the Ethics and Research Committee of the National Institute of Rehabilitation \u201cLuis Guillermo Ibarra Ibarra\u201d (Ref. number 51\/14). Informed consent was obtained from all individual participants included in the study. All participants were formally informed about the blood sample study and consented in writing to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to the manuscript sent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"228"}}